tiprankstipranks
Trending News
More News >
Cartesian Therapeutics, Inc. (RNAC)
:RNAC
Advertisement

Cartesian Therapeutics (RNAC) Revenue

Compare
1,114 Followers

Cartesian Therapeutics Revenue

Cartesian Therapeutics had a revenue of 1.10M in the quarter ending Mar 31, 2025, with 244.93%. This bring the company's revenue in the last twelve months to 34.17M, Increased -12.18%. In the fiscal year ending Dec 31, 2024, Cartesian Therapeutics had annual revenue of 38.91M with 49.64% growth.
Revenue (ttm)
34.17M
Revenue Growth
38.82%
P/S Ratio
8.98
Revenue/Employee
$589,591
Employees
66
Market Cap
$349.34M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
38.91M12.91M+49.64%
Dec 31, 2023
26.00M-84.77M-76.53%
Dec 31, 2022
110.78M25.70M+30.21%
Dec 31, 2021
85.08M68.48M+412.60%
Dec 31, 2020
16.60M9.92M+148.57%
Dec 31, 2019
6.68M5.77M+639.42%
Dec 31, 2018
903.00K696.00K+336.23%
Dec 31, 2017
207.00K-7.88M-97.44%
Dec 31, 2016
8.08M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis